The role of calcitonin in the prevention of osteoporosis.
This article discusses calcitonin as an alternative for patients with established osteoporosis who cannot, will not, or should not proceed with estrogen replacement therapy. Clinical trial data for calcitonin in both injectable and nasal spray formulations and for both lower-dose and higher-dose regimens are presented.
Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
L V
LV
Avioli
D002116:Calcitonin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*
D002116:Calcitonin